Details of the Drug Formulations

General Information of Drug (ID: DMFRM1I)

Drug Name
Canagliflozin Drug Info
Synonyms
842133-18-0; Invokana; Canagliflozin anhydrous; canagliflozin hemihydrate; UNII-6S49DGR869; JNJ-28431754; JNJ 24831754ZAE; Canagliflozin hydrate; TA-7284; 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene; CHEBI:73274; 6S49DGR869; (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; TA 7284; (1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol; 928672-86-0
Indication
Disease Entry ICD 11 Status REF
Non-insulin dependent diabetes 5A11 Approved [1]
Type-2 diabetes 5A11 Approved [2]
Diabetic nephropathy GB61.Z Phase 3 [3]
Type-1 diabetes 5A10 Phase 2 [4]
Cross-matching ID
PubChem CID
24812758
ChEBI ID
CHEBI:73274
CAS Number
842133-18-0
TTD ID
D08DFX
VARIDT ID
DR00279
INTEDE ID
DR0262
ACDINA ID
D00093

Full List of Drug Formulations Containing This Drug

Canagliflozin 100 mg tablet
Company Formulation ID FDA Description
Janssen Pharmaceutical F03185 Anhydrous lactose; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Canagliflozin 300 mg tablet
Company Formulation ID FDA Description
Janssen Pharmaceutical F03186 Anhydrous lactose; Magnesium stearate; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------

References

1 Canagliflozin FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4582).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)